Press

Field Trip Health & Wellness to Participate in Upcoming November Conferences

Oct 31 • 2 min read

Field Trip Health & Wellness Ltd. (TSXV: FTHW), the global leader in the development and delivery of psychedelic therapies, will participate in the following industry and investor conferences in November. Wonderland MicrodoseFormat: Panel Presentation with Mujeeb Jafferi, President, Field Trip Health & Wellness, “Are Apps the Future of Psychedelic Therapy?”Date/Time: Friday, November 4, at 1:20 p.m. ETLocation: Second…

ENOSIS THERAPEUTICS AND OVID CLINICS ANNOUNCE PARTNERSHIP TO LAUNCH WORLD’S FIRST IN-CLINIC APPLICATION OF VIRTUAL REALITY MODULATED PSYCHEDELIC-AUGMENTED PSYCHOTHERAPY

Oct 31 • 4 min read

Enosis Therapeutics, a medical technology and psychedelic research company that leverages virtual reality (VR) for the contextual modulation of psychedelic therapy to improve treatment outcomes, has partnered with OVID Clinics and the MIND Foundation to implement the world’s first in-clinic application of VR with Psychedelic-Assisted therapy. The Berlin-based healthcare services provider that delivers integration-focused and psychedelic-based…

Better U Expanding Psychedelic-Assisted Therapies to 9 States with Immersive Healing Centers

Oct 31 • 3 min read

Better U, a leading psychedelic-assisted therapy platform developed by psychiatrist Dr. Sam Zand, announced today the expansion of their telemedicine platform to include immersive psychedelic healing centers. “At-home ketamine treatments are not suitable for everyone. Transitioning to a hybrid model allows us to provide additional care for a greater portion of the population that are struggling with…

Small Pharma Receives Approval for First-In-Human Phase I Clinical Trial With SPL028

Oct 31 • 3 min read

Small Pharma Inc. (TSXV: DMT | OTCQB: DMTTF), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that it has received approval from the U.K. Medicines and Healthcare products Regulatory Authority (the “MHRA”) and the Research Ethics Committee to initiate a Phase I study of SPL028, its proprietary deuterated N,…

Numinus to Participate in Wonderland: Miami on November 3-5, 2022

Oct 31 • 1 min read

Numinus Wellness Inc. (TSX: NUMI | OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in Wonderland: Miami hosted by Microdose to be held at the Mana Wynwood Convention Center in Miami, FL on November 3-5, 2022. Dr. Reid Robison, MD MBA, Chief Clinical Officer of Numinus, will participate in…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435